Sunshine Biopharma Inc. Income (Loss) from Continuing Operations, Per Basic Share
Sunshine Biopharma Inc. (SBFM) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.01 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2021-03-30
- Sunshine Biopharma Inc. income (loss) from continuing operations, per basic share for the quarter ending 2020-09-30 was $0.00.
- Sunshine Biopharma Inc. income (loss) from continuing operations, per basic share for the quarter ending 2020-06-30 was -$0.01.
- Sunshine Biopharma Inc. income (loss) from continuing operations, per basic share for the quarter ending 2020-03-31 was $0.00.
- Sunshine Biopharma Inc. income (loss) from continuing operations, per basic share for the quarter ending 2019-09-30 was -$0.04.
- Sunshine Biopharma Inc. income (loss) from continuing operations, per basic share for fiscal 2020 was -$0.01.
- Sunshine Biopharma Inc. income (loss) from continuing operations, per basic share for fiscal 2019 was -$0.10.
- Sunshine Biopharma Inc. income (loss) from continuing operations, per basic share for fiscal 2018 was -$0.70.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$0.01 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | -$0.01 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | -$0.01 10-Q/A · filed 2020-08-31 | -$0.01 10-Q/A · filed 2020-08-31 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-18 | |||
| 2019-12-31 | -$0.10 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$0.04 10-Q · filed 2020-11-12 | -$0.15 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$0.03 10-Q/A · filed 2020-08-31 | -$0.07 10-Q/A · filed 2020-08-31 | ||
| 2019-03-31 | -$0.05 10-Q · filed 2020-05-18 | |||
| 2018-12-31 | -$0.70 10-K · filed 2020-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |